Treatment of Acute Osteomyelitis with Once-Weekly Oritavancin: A Two-Year, Multicenter, Retrospective Study

BACKGROUND: Acute osteomyelitis is typically caused by Gram-positive pathogens, commonly antibiotic-resistant Staphylococcus species. Standard antibiotic treatment is challenging due to required multiple daily doses, therapeutic drug monitoring, and parenteral administration for at least 4 weeks. Or...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Drugs Real World Outcomes
Главные авторы: Van Hise, Nicholas W., Chundi, Vishnu, Didwania, Vishal, Anderson, Michael, McKinsey, David, Roig, Ingrid, Sharma, Akhilesh, Petrak, Russell M.
Формат: Artigo
Язык:Inglês
Опубликовано: Springer International Publishing 2020
Предметы:
Original Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7334313/
https://ncbi.nlm.nih.gov/pubmed/32588385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-020-00195-7
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы